公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2008 | Intra-abdominal adhesion formation induces anti-oxidative injury, enhances cell proliferation, and prevents complement-mediated lysis | SUNG-LIANG YU ; Singh S.; HUEI-WEN CHEN ; Chen H.-Y.; Chen J.J.W.; WEN-JONE CHEN ; Chen H.-S.; SHYR-CHYR CHEN | Wound Repair and Regeneration | 5 | 4 | |
2020 | Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma | Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN ; SUNG-LIANG YU ; SHENG-FANG SU ; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; PAN-CHYR YANG ; Chang G.-C.; Chen H.-Y. | Cancers | 8 | 8 | |
2008 | MicroRNA Signature Predicts Survival and Relapse in Lung Cancer | SUNG-LIANG YU ; HSUAN-YU CHEN; Chang G.-C.; Chen C.-Y.; HUEI-WEN CHEN ; Singh S.; Cheng C.-L.; CHONG-JEN YU ; Lee Y.-C.; Chen H.-S.; Su T.-J.; Chiang C.-C.; Li H.-N.; Hong Q.-S.; Su H.-Y.; Chen C.-C.; Chen, W.-J.; Liu C.-C.; Chan W.-K.; WEI J. CHEN ; Li K.-C.; Chen J.J.W.; PAN-CHYR YANG | Cancer Cell | 725 | 672 | |
2008 | Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPα | Wu C.-C.; Lin J.-C.; Yang S.-C.; Lin C.-W.; Chen J.J.W.; JIN-YUAN SHIH ; Hong T.-M.; PAN-CHYR YANG | Molecular Cancer Therapeutics | 16 | 16 | |
2006 | Multifunctional transcription factor YY1: A therapeutic target in human cancer? | Wang C.-C.; Chen J.J.W.; PAN-CHYR YANG | Expert Opinion on Therapeutic Targets | 46 | 39 | |
2006 | A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma | Tsai M.-F.; Wang C.-C.; Chang G.-C.; Chen C.-Y.; Chen H.-Y.; Cheng C.-L.; Yang Y.-P.; Wu C.-Y.; Shih F.-Y.; Liu C.-C.; Lin H.-P.; Jou Y.-S.; Lin S.-C.; CHUNG-WU LIN ; WEI J. CHEN ; Chan W.-K.; Chen J.J.W.; PAN-CHYR YANG | Journal of the National Cancer Institute | 101 | 98 | |
2012 | A novel function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis | Chen C.-H.; Chuang S.-M.; Yang M.-F.; Liao J.-W.; SUNG-LIANG YU ; Chen J.J.W. | Molecular Cancer Research | 77 | 78 | |
2016 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma | Su T.-J.; Ku W.-H.; Chen H.-Y.; Hsu Y.-C.; Hong Q.-S.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | American Journal of Cancer Research | 22 | ||
2015 | Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression | ANG YUAN ; Hsiao Y.-J.; Chen H.-Y.; HUEI-WEN CHEN ; CHAO-CHI HO ; Chen Y.-Y.; Liu Y.-C.; Hong T.-H.; SUNG-LIANG YU ; Chen J.J.W.; PAN-CHYR YANG | Scientific Reports | 258 | 229 | |
2015 | PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma | Huang A.-H.; SZU-HUA PAN ; Chang W.-H.; Hong Q.-S.; Chen J.J.W.; SUNG-LIANG YU | PLoS ONE | 24 | 24 | |
2016 | Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition | Lin S.-Y.; Lee Y.-X.; SUNG-LIANG YU ; Chang G.-C.; Chen J.J.W. | Oncotarget | 7 | 7 | |
2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
1998 | Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection | Chen J.J.W.; Wu R.; PAN-CHYR YANG ; Huang JY; Sher YP; Han MH; Kao WC; Lee PJ; Chiu TF; Chang F; Chu YW; Wu CW; Peck K | Genomics | 204 | 172 | |
2000 | Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray | Hong T.-M.; PAN-CHYR YANG ; Peck K.; Chen J.J.W.; Yang S.-C.; Chen Y.-C.; Wu C.-W. | American Journal of Respiratory Cell and Molecular Biology | 73 | 67 | |
2015 | R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability | Chen H.-Y.; SUNG-LIANG YU ; Ho B.-C.; KANG-YI SU ; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; KUAN-YU CHEN ; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN ; Chen J.J.W.; Chen C.-J.; Chang G.-C.; PAN-CHYR YANG ; Li K.-C. | Journal of Clinical Oncology | 76 | 71 | |
2015 | Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways | Lai Y.-H.; Chen M.-H.; Lin S.-Y.; Lin S.-Y.; Wong Y.-H.; SUNG-LIANG YU ; HUEI-WEN CHEN ; CHIH-HSIN YANG ; Chang G.-C.; Chen J.J.W. | Oncotarget | 10 | 8 | |
2014 | Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer | Chen C.-C.; Chen H.-Y.; KANG-YI SU ; Hong Q.-S.; BO-SHIUN YAN ; Chen C.-H.; SZU-HUA PAN ; YIH-LEONG CHANG ; Wang C.-J.; Hung P.-F.; Yuan S.; Chang G.-C.; Chen J.J.W.; PAN-CHYR YANG ; YA-CHIEN YANG ; SUNG-LIANG YU | American Journal of Respiratory and Critical Care Medicine | 30 | 33 | |
2012 | Single-walled carbon nanotubes induce airway hyperreactivity and parenchymal injury in mice | Hsieh W.-Y.; Chou C.-C.; CHAO-CHI HO ; SUNG-LIANG YU ; Chen H.-Y.; HAN-YI E. CHOU ; Chen J.J.W.; HUEI-WEN CHEN ; PAN-CHYR YANG | American Journal of Respiratory Cell and Molecular Biology | 31 | 27 | |
2016 | Small molecule T315 promotes casitas b-lineage lymphoma dependent degradation of epidermal growth factor receptor via Y1045 autophosphorylation | Huang K.-Y.; Kao S.-H.; Wang W.-L.; Chen C.-Y.; Hsiao T.-H.; Salunke S.B.; Chen J.J.W.; KANG-YI SU ; Yang S.-C.; Hong T.-M.; Chen C.-S.; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 18 | 18 | |
2007 | Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1 | Wang C.-C.; Tsai M.-F.; Dai T.-H.; Hong T.-M.; Chan W.-K.; Chen J.J.W.; PAN-CHYR YANG | Cancer Research | 55 | 48 |